|
Name |
Isoeugenitol
|
| Molecular Formula | C11H10O4 | |
| IUPAC Name* |
5,7-dihydroxy-2,8-dimethylchromen-4-one
|
|
| SMILES |
CC1=CC(=O)C2=C(C=C(C(=C2O1)C)O)O
|
|
| InChI |
InChI=1S/C11H10O4/c1-5-3-8(13)10-9(14)4-7(12)6(2)11(10)15-5/h3-4,12,14H,1-2H3
|
|
| InChIKey |
XSSGQRFNGHRFBC-UHFFFAOYSA-N
|
|
| Synonyms |
Isoeugenitol; 5,7-dihydroxy-2,8-dimethylchromone; 479-06-1; KBio1_001073; Spectrum_000601; SpecPlus_000033; Spectrum2_000569; Spectrum3_000687; Spectrum4_001501; Spectrum5_000261; BSPBio_002413; KBioGR_002161; KBioSS_001081; SPECTRUM200449; DivK1c_006129; SPBio_000358; CHEMBL1371435; SCHEMBL18517012; CHEBI:92103; KBio2_001081; KBio2_003649; KBio2_006217; KBio3_001633; DTXSID601318026; CCG-38735; SDCCGMLS-0066885.P001; NCGC00095479-01; NCGC00095479-02; NCGC00178664-01; 5,7-dihydroxy-2,8-dimethyl-4H-chromen-4-one; 5,7-dihydroxy-2,8-dimethyl-1-benzopyran-4-one; BRD-K05737787-001-02-2; Q27163895
|
|
| CAS | 479-06-1 | |
| PubChem CID | 5318562 | |
| ChEMBL ID | CHEMBL1371435 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 206.19 | ALogp: | 2.1 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 15 | QED Weighted: | 0.694 |
| Caco-2 Permeability: | -4.793 | MDCK Permeability: | 0.00001040 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.892 |
| Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.017 |
| 30% Bioavailability (F30%): | 0.563 |
| Blood-Brain-Barrier Penetration (BBB): | 0.02 | Plasma Protein Binding (PPB): | 90.04% |
| Volume Distribution (VD): | 0.66 | Fu: | 12.12% |
| CYP1A2-inhibitor: | 0.978 | CYP1A2-substrate: | 0.952 |
| CYP2C19-inhibitor: | 0.155 | CYP2C19-substrate: | 0.141 |
| CYP2C9-inhibitor: | 0.372 | CYP2C9-substrate: | 0.86 |
| CYP2D6-inhibitor: | 0.513 | CYP2D6-substrate: | 0.515 |
| CYP3A4-inhibitor: | 0.179 | CYP3A4-substrate: | 0.215 |
| Clearance (CL): | 8.444 | Half-life (T1/2): | 0.795 |
| hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.087 |
| Drug-inuced Liver Injury (DILI): | 0.941 | AMES Toxicity: | 0.585 |
| Rat Oral Acute Toxicity: | 0.188 | Maximum Recommended Daily Dose: | 0.772 |
| Skin Sensitization: | 0.817 | Carcinogencity: | 0.151 |
| Eye Corrosion: | 0.169 | Eye Irritation: | 0.94 |
| Respiratory Toxicity: | 0.369 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001518 | ![]() |
0.667 | D0FA2O | ![]() |
0.381 | ||
| ENC001940 | ![]() |
0.667 | D0G4KG | ![]() |
0.368 | ||
| ENC004786 | ![]() |
0.608 | D04AIT | ![]() |
0.342 | ||
| ENC006031 | ![]() |
0.566 | D0K8KX | ![]() |
0.299 | ||
| ENC001755 | ![]() |
0.538 | D06GCK | ![]() |
0.298 | ||
| ENC004675 | ![]() |
0.537 | D07MGA | ![]() |
0.263 | ||
| ENC005717 | ![]() |
0.528 | D0O6KE | ![]() |
0.261 | ||
| ENC005716 | ![]() |
0.528 | D0N0OU | ![]() |
0.245 | ||
| ENC001495 | ![]() |
0.509 | D0Y7PG | ![]() |
0.237 | ||
| ENC001617 | ![]() |
0.500 | D0H2ZW | ![]() |
0.232 | ||